Table 3 Proteins differentially expressed in serum from patients undergoing aseptic hip revision (AL) and primary THA (PR), as quantified using specific-antibody arrays (in all proteins, p = 0.0357).
From: Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening
Protein | UniProtKB Accession number | Molecular function (GO) and biological process | Protein levels (pg/mL) Median value (range) | |
|---|---|---|---|---|
AL | PR | |||
IGFBP-1 | P08833 | Tissue regeneration/cell growth | 7978 (7762–10,429) | 3512 (2733–4303) |
ErbB2 | P04626 | Immune response/wound healing/angiogenesis | 4.3 (3.6–4.5) | 9.0 (5.5–9.8) |
FABP2 | P12104 | Transport/triglyceride catabolic process/fatty acid binding | 509 (333–747) | 163 (119–286) |
PECAM-1 | P16284 | Phagocytosis/Cell adhesion/ECM organization/signal transduction | 2032 (1375–4253) | 912 (595–1103) |
